Revvity (RVTY) Liabilities and Shareholders Equity (2010 - 2026)
Revvity (RVTY) reported Liabilities and Shareholders Equity of $12.0 billion for Q2 2026, down 2.95% on a YoY basis from $12.4 billion in Q2 2025, and down 1.41% quarter-over-quarter from $12.2 billion in Q4 2025.
Revvity (RVTY) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Revvity has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $12.0 billion in Q2 2026.
- For the quarter ending Q2 2026, Liabilities and Shareholders Equity fell 2.95% year-over-year to $12.0 billion; the trailing twelve-month figure through Apr 2026 stood at $48.7 billion (down 4.48% YoY), and the FY2025 full-year result was $12.2 billion, down 1.81% from the prior year.
- Liabilities and Shareholders Equity for Q2 2026 stood at $12.0 billion, down from $12.2 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $15.0 billion in Q1 2022, with the low at $12.0 billion in Q2 2026.
- Historically, Liabilities and Shareholders Equity has averaged $13.4 billion across 5 years, with a median of $13.4 billion in 2024.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 88.44% — and 2024, when it fell 8.64%.
- Revvity's Liabilities and Shareholders Equity stood at $13.8 billion in 2022, then fell by 1.87% to $13.6 billion in 2023, then fell by 8.64% to $12.4 billion in 2024, then slipped by 1.81% to $12.2 billion in 2025, then declined by 1.41% to $12.0 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $12.0 billion (Q2 2026), $12.2 billion (Q4 2025), and $12.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 24.53 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 113.28 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 83.54 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 3.39 Bn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 13.07 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 2.61 Bn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 29.68 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 6.56 Bn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 3.67 Bn |
| 10 | Revvity | 11.63 Bn | 10.77 Bn | 387.66 Mn | 12.00 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | 12.00 Bn |
| Dec 28, 2025 | 12.17 Bn |
| Sep 28, 2025 | 12.14 Bn |
| Jun 29, 2025 | 12.36 Bn |
| Mar 30, 2025 | 12.36 Bn |
| Dec 29, 2024 | 12.39 Bn |
| Sep 29, 2024 | 12.77 Bn |
| Jun 30, 2024 | 13.42 Bn |
| Mar 31, 2024 | 13.43 Bn |
| Dec 31, 2023 | 13.56 Bn |
| Oct 1, 2023 | 13.42 Bn |
| Jul 2, 2023 | 14.22 Bn |
| Apr 2, 2023 | 14.64 Bn |
| Jan 1, 2023 | 14.13 Bn |
| Oct 2, 2022 | 13.82 Bn |
| Jul 3, 2022 | 14.19 Bn |
| Apr 3, 2022 | 14.85 Bn |
| Jan 2, 2022 | 15.00 Bn |
| Oct 3, 2021 | 14.90 Bn |
| Jul 4, 2021 | 8.74 Bn |